Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, pharmacy benefit manager Express Scripts (NASDAQ:ESRX) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Express Scripts and see what CAPS investors are saying about the stock right now.

Express Scripts facts

Headquarters (founded)

St. Louis (1986)

Market Cap

$44.3 billion

Industry

Healthcare services

Trailing-12-Month Revenue

$78.9 billion

Management

Chairman/CEO George Paz

CFO Jeffrey Hall

Return on Equity (average, past 3 years)

30.4%

Cash / Debt

$1.3 billion / $17.1 billion

Competitors

Catamaran (UNKNOWN:CTRX.DL)
CVS Caremark (NYSE:CVS)

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 94% of the 795 members who have rated Express Scripts believe the stock will outperform the S&P 500 going forward.

Just last month, one of those Fools, mwlove, tapped the stock as a particularly attractive investment candidate:

[T]he synergies of the Medco merger are paying off handsomely, and Express Scripts will benefit from health care reform. The market has over-reacted to management talk of "overly aggressive" forecasts. Other than that [faux pas], management has been exemplary and will take the company forward to a very bright future.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.